Argent Trust Co’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$300K Sell
2,197
-614
-22% -$75.4K 0.01% 645
2026
Q1
$331K Buy
2,811
+353
+14% +$49.3K 0.01% 579
2025
Q4
$403K Buy
+2,458
New +$385K 0.01% 505
2025
Q2
Sell
-1,667
Closed -$212K 729
2025
Q1
$212K Buy
+1,667
New +$257K 0.01% 648

Other funds holding RGEN

Argent Trust Co's RGEN Position: Q2 2026 in Review

Argent Trust Co reduced its Repligen (RGEN) stake by 22% in Q2 2026, selling an estimated $75.4K and leaving 2,197 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #645.

Argent Trust Co first reported a position in RGEN in Q1 2025 and has held it in 4 quarters since. The position peaked at $403K in Q4 2025. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Argent Trust Co held 2,197 shares of Repligen worth $300K as of Q2 2026.
  • Argent Trust Co sold 614 Repligen shares in Q2 2026, an estimated $75.4K.
  • Repligen made up 0.01% of Argent Trust Co's portfolio in Q2 2026, its #645 holding.
  • Argent Trust Co first reported a position in Repligen in Q1 2025 and has held it in 4 quarters since.
  • Argent Trust Co's Repligen position peaked at $403K in Q4 2025.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.